DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1759)

Category

1525 Biopharma Reports

Heart failure with preserved ejection fraction ( HFpEF ) occurs due to abnormal...
Heart failure with preserved ejection fraction ( HFpEF ) occurs due to abnormal relaxation and filling of the left ventricle. Despite the fact that HFpEF accounts for nearly half of all CHF cases, th......
Treatment of heart failure with reduced ejection fraction ( HFrEF ) is well-...
Treatment of heart failure with reduced ejection fraction ( HFrEF ) is well-established with a wealth of evidence from clinical trials that support the use of all standard-of-care therapies for CHF .......
1 - 20 of 1525